Product Images Metoprolol Succinate

This is a description of a medication in tablet form called Metoprolol Succinate Extended-Release Tablets. It contains 190 mg of metoprolol succinate, USP, which is equivalent to 200 mg of metoprolol tartrate, USP. The medication is manufactured by Alkem Laboratories Ltd. in India and distributed by BluePoint Laboratories. The dosage information is available in the package insert, and caution is advised as with all medications to be kept out of the reach of children. The medication should be stored at room temperature between 15°C-30°C.*

Each film-coated tablet contains 23.75 mg metoprolol succinate, USP equivalent to 25 mg of metoprolol. The tablets are extended-release and should be kept out of the reach of children. They should be stored at room temperature and dispensed according to the USP guidelines. This product is manufactured by Alkem Laboratories Ltd in India. This label provides important dosage and warning information for Metoprolol Succinate ER Tablets.*

This is a medication label for Metoprolol Succinate ER tablets, with a prescribed dosage of 50mg. The medication should be stored at 25°C and protected from light. The label includes a warning about the medication's potential side effects. The tablets were manufactured by UCB Pharma for Bausch Health Companies and the package contains 100 tablets.*

This text contains the results for subgroups in MERIT-HF trial, a clinical study evaluating the effectiveness of metoprolol succinate extended-release tablets on heart failure. The data shows the relative risk and 95% confidence interval for total mortality, all-cause hospitalization, and hospitalization for heart failure based on different factors such as age, gender, race, previous medical conditions, and heart rate. The information is presented in a table format with some abbreviations defined.*